-
公开(公告)号:US20180361015A1
公开(公告)日:2018-12-20
申请号:US15780229
申请日:2016-11-29
发明人: Kelly A. Burke , David L. Kaplan
摘要: In some embodiments, the present invention provides compositions including silk fibroin, at least one hydrophilic agent, and at least one catechol donating agent, wherein the at least one hydrophilic agent and at least one catechol donating agent are conjugated to the silk fibroin. According to various embodiments, at least a portion of the silk fibroin may be crosslinked. In some embodiments, the silk fibroin is at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or more) crosslinked. In some embodiments, the present invention also provides methods for making such compositions.
-
公开(公告)号:US20180360947A1
公开(公告)日:2018-12-20
申请号:US15858239
申请日:2017-12-29
IPC分类号: A61K39/20 , A61K39/165 , A61K39/04 , A61K47/46 , A61K9/00 , A61K9/06 , A61K9/14 , A61K9/19 , A61K9/50 , A61K9/70 , B82Y5/00 , A61K39/00 , A61K39/02 , A61K39/12 , A61K39/095 , A61K39/09 , A61K39/08 , A61K47/42 , A61K38/00
摘要: Provided herein are methods and compositions for stabilization of active agents. The active agents are distributed, mixed or embedded in a silk fibroin matrix, thereby retaining the bioactivity of the active agents upon storage and/or transportation. In some embodiments, the storage-stable vaccine-silk compositions are also provided herein.
-
公开(公告)号:US20180258389A1
公开(公告)日:2018-09-13
申请号:US15757056
申请日:2016-09-09
发明人: Dana Cairns , David L. Kaplan
IPC分类号: C12N5/0797 , C12N15/67 , C12N15/85
摘要: In some embodiments, the present invention provides methods including the steps of providing one or more human somatic cells, causing transient increased expression of OCT4, KLF4, SOX2, and cMYC in the somatic cells forming modified somatic cells, providing a plurality of inactivated embryonic fibroblasts, associating the modified somatic cells with the inactivated embryonic fibroblasts in a culture media comprising 20% KO DMEM xeno-free serum replacement and at least 15 ng/ml recombinant bFGF to form human induced neural stem cells.
-
124.
公开(公告)号:US10034945B2
公开(公告)日:2018-07-31
申请号:US14414245
申请日:2013-07-15
发明人: David L. Kaplan , Fiorenzo Omenetto , Gary G. Leisk , Tim Jia-Ching Lo , Benjamin Partlow , Rosario Friedman
IPC分类号: A61K47/42 , B30B9/28 , A61L31/04 , A43B1/02 , A43B1/06 , A43B13/02 , A43B23/02 , A61L27/36 , A61L27/50
CPC分类号: A61K47/42 , A43B1/02 , A43B1/06 , A43B13/02 , A43B23/0205 , A43B23/0225 , A61L27/3604 , A61L27/50 , A61L31/047 , B30B9/28 , Y10T29/49
摘要: The present disclosure relates generally to compositions and methods for production of three-dimensional constructs with high mechanical strength and/or stiffness.
-
公开(公告)号:US09993527B2
公开(公告)日:2018-06-12
申请号:US13680570
申请日:2012-11-19
IPC分类号: A61K38/18 , A61K47/42 , A61L27/38 , A61L27/56 , A61L27/22 , A61L27/26 , A61L27/36 , D01D5/00 , D01F4/02 , C12N5/00 , C12N5/079
CPC分类号: A61K38/1825 , A61K38/1841 , A61K47/42 , A61L27/227 , A61L27/26 , A61L27/3604 , A61L27/3847 , A61L27/3852 , A61L27/3895 , A61L27/56 , D01D5/00 , D01F4/02 , Y10T428/29 , C08L89/00
摘要: The present invention provides processes for producing porous silk fibroin scaffold material. The porous silk fibroin scaffold can be used for tissue engineering. The porosity of the silk fibroin scaffolds described herein can be adjusted as to mimic the gradient of densities found in natural tissue. Accordingly, methods for engineering of 3-dimensional tissue, e.g. bone and cartilage, using the silk fibroin scaffold material are also provided.
-
公开(公告)号:US09925301B2
公开(公告)日:2018-03-27
申请号:US14390362
申请日:2013-04-05
发明人: David L. Kaplan , Biman B. Mandal
IPC分类号: A61L27/36 , A61L27/56 , D02J1/00 , D01C3/00 , D04H1/4266 , D06M11/36 , A61L27/54 , A61L27/58 , C08J5/04 , A61L27/38 , C08K7/02 , A61L27/48 , D06M101/12
CPC分类号: A61L27/3604 , A61L27/365 , A61L27/3687 , A61L27/3821 , A61L27/3834 , A61L27/48 , A61L27/54 , A61L27/56 , A61L27/58 , A61L2400/06 , A61L2430/02 , C08J5/045 , C08K7/02 , D01C3/00 , D02J1/00 , D04H1/4266 , D06M11/36 , D06M2101/12
摘要: Provided herein relates to methods for preparing micron range silk fibers (or silk microfibers) and compositions comprising a micron range silk fiber (or a silk microfiber). The micron range silk fibers (or silk microfibers) can be used in various applications ranging from fillers in cosmetics to reinforcement materials to design high strength composites, e.g., reinforced scaffolds. In some embodiments, the silk microfiber-reinforced scaffolds can be used for bone graft applications because of their high compressive strength.
-
公开(公告)号:US09731052B2
公开(公告)日:2017-08-15
申请号:US14705509
申请日:2015-05-06
发明人: David L. Kaplan , Xianyan Wang
IPC分类号: A61L27/22 , A61L27/40 , C09D189/00 , A61L31/10 , A61L15/32 , A61L31/16 , A61L15/44 , A61L27/36 , A61L27/50 , A61K38/00
CPC分类号: A61L31/10 , A61J3/00 , A61L15/32 , A61L15/44 , A61L27/3604 , A61L27/50 , A61L31/16 , A61L2300/416 , A61L2300/43 , A61L2400/12 , A61L2400/18 , C09D189/00 , Y10T428/31768
摘要: The invention provides a method for the controlled assembly of layered silk fibroin coatings using aqueous silk fibroin material. The methods described herein can be used to coat substrates of any material, shape, or size. Importantly, the described methods enable control of the biomaterial surface chemistry, thickness, morphology and structure using layered thin film coatings, or bulk coatings. Furthermore, the methods can be performed in all water and do not require intensive chemical processing enabling controlled entrapment of labile molecules such as, drugs, cytokines, and even cells or viruses to generate functional coatings that can be used in a variety of applications.
-
公开(公告)号:US09655993B2
公开(公告)日:2017-05-23
申请号:US14793464
申请日:2015-07-07
发明人: David L. Kaplan , Fiorenzo Omenetto , Jeffrey K. Marchant , Noorjahan Panjwani , Brian Lawrence
CPC分类号: A61L27/3604 , A61L27/225 , A61L27/227 , A61L27/3804 , A61L27/3839 , A61L27/3891 , A61L27/56 , A61L2300/412 , C12N5/0068 , C12N5/0621 , C12N2533/50 , G01N33/5044
摘要: This invention relates to a lamellae tissue layer, comprising a grooved silk fibroin substrate comprising tissue-specific cells. The silk fibroin substrates provides an excellent means of controlling and culturing cell and extracellular matrix development. A multitude of lamellae tissue layers can be used to create a tissue-engineered organ, such as a tissue-engineered cornea. The tissue-engineered organ is non-immunogenic and biocompatible.
-
公开(公告)号:US09554989B2
公开(公告)日:2017-01-31
申请号:US14386545
申请日:2013-03-11
发明人: David L. Kaplan , Tuna Yucel , Michael L. Lovett , Xiaoqin Wang
CPC分类号: A61K9/0024 , A61K9/0019 , A61K9/0092 , A61K9/4825 , A61K9/5052 , A61K31/00 , A61K31/13 , A61K31/5415
摘要: The present invention is directed to silk-based drug delivery compositions for controlled, sustained delivery of therapeutic agent(s) as well as methods of making and using the same.
摘要翻译: 本发明涉及用于受控,持续递送治疗剂的丝基药物递送组合物及其制备和使用方法。
-
公开(公告)号:US09381164B2
公开(公告)日:2016-07-05
申请号:US14216756
申请日:2014-03-17
发明人: Xiaoqin Wang , David L. Kaplan
CPC分类号: A61K9/5169 , A61K9/14 , A61K9/1605 , A61K9/1647 , A61K9/5052 , A61K9/5089 , A61K9/5192 , A61K31/352 , Y10T428/2982
摘要: The present invention provides for methods of preparing silk nanoparticles and microparticles, methods of encapsulating an active agent into the silk nano- and microparticles and compositions comprising these silk particles. In particular, the silk spheres are prepared from phase separation of silk and polyvinyl alcohol (PVA), without exposure to an organic solvent. The method employs a chemical, PVA, which is an FDA-approved ingredient in drug formulations. Different parameters can be adjusted to control the size and shape of the silk spheres during the fabrication process. The silk particle compositions of the present invention may also encapsulate active agents or chemicals. Such compositions allow the active agents to be controllably and sustainably released to the target organs or tissues. The silk composition entrapping active agents also provides for a long-term storage medium for the active agents so entrapped. The silk nano- and microparticles of the present invention are thus suitable for a variety of biomedical and pharmaceutical applications, such as drug delivery or tissue engineering.
摘要翻译: 本发明提供了制备丝纳米颗粒和微粒的方法,将活性剂包封在丝纳米和微粒中的方法和包含这些丝颗粒的组合物。 特别地,丝球是通过丝和聚乙烯醇(PVA)的相分离制备的,而不暴露于有机溶剂。 该方法采用化学品PVA,它是FDA批准的药物制剂成分。 可以调整不同的参数,以在制造过程中控制丝球的尺寸和形状。 本发明的丝粒组合物也可以包封活性剂或化学物质。 这样的组合物允许活性剂可控地和可持续地释放到靶器官或组织。 包埋活性剂的丝绸组合物还为被捕获的活性剂提供长期的储存介质。 因此,本发明的丝素纳米颗粒和微粒子适用于各种生物医学和药物应用,例如药物递送或组织工程。
-
-
-
-
-
-
-
-
-